Vitaliy V. Shabanov

Vitaliy V. Shabanov

Auto-generated profile, based on publicly available information

Vitaliy V. Shabanov

Academician E.N. Meshalkin National Medical Research Center, Novosibirsk

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Heart Rhythm
Verified
Journal Article
Closed access
JSJonathan S. Steinberg
Jonathan S. Steinberg
ARAlexander Romanov
Alexander Romanov
DMDan Musat
Dan Musat
MPMark Preminger
Mark Preminger
SBSevda Bayramova
Sevda Bayramova
EPEvgeny Pokushalov
Evgeny Pokushalov

12 November 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
EMEvgeny N Mikhaylov
Evgeny N Mikhaylov
DLDlebedev Lebedev
Dlebedev Lebedev
EPEvgeny Pokushalov
Evgeny Pokushalov
KDKarapet V. Davtyan
Karapet V. Davtyan
EIEduard A. Ivanitskii
Eduard A. Ivanitskii
ESEvgeny V. Shlyakhto
Evgeny V. Shlyakhto
Purpose. The results of cryoballoon ablation (CBA) procedure have been mainly derived from studies conducted in experienced atrial fibrillation (AF) ablation centres. Here, we report on CBA efficacy and complications resulting from real practice of this procedure at both high- and low-volume centres. Methods. Among 62 Russian centres performing AF ablation, 15 (24%) used CBA technology for pulmonary vein isolation. The centres were asked to provide a detailed description of all CBA procedures performed and complications, if encountered. Results. Thirteen sites completed interviews on all CBAs in their centres (>95% of CBAs in Russia). Six sites were high-volume AF ablation (>100 AF cases/year) centres, and 7 were low-volume AF ablation. There was no statistical difference in arrhythmia-free rates between high- and low-volume centres (64.6 versus 60.8% at 6 months). Major complications developed in 1.5% of patients and were equally distributed between high- and low-volume centres. Minor procedure-related events were encountered in 8% of patients and were more prevalent in high-volume centres. Total event and vascular access site event rates were higher in women than in men. Conclusions. CBA has an acceptable efficacy profile in real practice. In less experienced AF ablation centres, the major complication rate is equal to that in high-volume centres. Purpose. The results of cryoballoon ablation (CBA) procedure have been mainly derived from studies conducted in experienced atrial fibrillation (AF) ablation centres. Here, we report on CBA efficacy and complications resulting from real practice of this procedure at both high- and low-volume centres. Methods. Among 62 Russian centres performing AF ablation, 15 (24%) used CBA technology for pulmonary vein isolation. The centres were asked to provide a detailed description of all CBA procedures performed and complications, if encountered. Results. Thirteen sites completed interviews on all CBAs in their centres (>95% of CBAs in Russia). Six sites were high-volume AF ablation (>100 AF cases/year) centres, and 7 were low-volume AF ablation. There was no statistical difference in arrhythmia-free rates between high- and low-volume centres (64.6 versus 60.8% at 6 months). Major complications developed in 1.5% of patients and were equally distributed between high- and low-volume centres. Minor procedure-related events were encountered in 8% of patients and were more prevalent in high-volume centres. Total event and vascular access site event rates were higher in women than in men. Conclusions. CBA has an acceptable efficacy profile in real practice. In less experienced AF ablation centres, the major complication rate is equal to that in high-volume centres.

30 December 2015 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
ARAlexander Romanov
Alexander Romanov
KGKinga Gościńska-Bis
Kinga Gościńska-Bis
JBJaroslaw Bis
Jaroslaw Bis
ACAlexander Chernyavskiy
Alexander Chernyavskiy
DPDarya Prokhorova
Darya Prokhorova
EPEvgeny Pokushalov
Evgeny Pokushalov
Totally epicardial cardiac resynchronization therapy (CRT) is a novel treatment modality for patients with heart failure (HF) and systolic dyssynchrony undergoing coronary artery bypass grafting (CABG). In this study, we have prospectively evaluated the long-term outcomes of totally epicardial CRT. Between September 2007 and June 2009, one hundred and seventy-eight patients were randomly assigned to the CABG alone group ( n = 87) and CABG with concomitant epicardial CRT implantation ( n = 91). The primary end-point of the study was all-cause mortality in the two groups between the day of surgery and 13 August 2013 (common closing date). The secondary outcomes included mode of death, adverse cardiac events and lead performance. The mean follow-up was 55 ± 10.7 months. According to per-protocol analysis with treatment as a time-dependent variable to account for conversion from CABG to CABG + CRT, there were 24 deaths (35.8%) in the CABG group and 17 deaths (15.3%) in the CABG + CRT group. When compared with CABG alone, concomitant CRT was associated with reduced risk of both all-cause mortality [hazard ratio (HR) 0.43, 95% confidence interval (CI) 0.23–0.84, P = 0.012] and cardiac death (HR 0.39, 95% CI 0.21–0.72, P = 0.002). Eleven (12.6%) sudden deaths were observed in the CABG group in comparison with 4 (4.4%) in the CABG + CRT group ( P = 0.048). Hospital readmission was required for 9 (9.9%) patients in CABG + CRT group and for 25 (28.7%) patients in the CABG group ( P = 0.001). There were 4 (1.5%) epicardial lead failures. The results of our study suggest that the procedure of CABG and totally epicardial CRT system implantation is safe and significantly improves the survival of patients with HF and dyssynchrony during long-term follow-up. NCT 00846001 ( http://www.clinicaltrials.gov ).

22 January 2024 in Journal of Arrhythmology
Verified
Journal Article
Open access
PDF file
NGN. Z. Gasimova
N. Z. Gasimova
VSV. V. Shabanov
V. V. Shabanov
NSN. V. Safonov
N. V. Safonov
FRF. G. Rzayev
F. G. Rzayev
AFA. G. Filatov
A. G. Filatov
EMEvgeny N Mikhaylov
Evgeny N Mikhaylov
This article brings together the opinions of leading experts in the field of cardiac arrhythmia interventional treatment using multipolar mapping. The advantages and applicability of the PENTARAY® NAV eco mapping catheter are discussed in detail.

1 February 2021 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
ARAlexander Romanov
Alexander Romanov
AFAlexey Filippenko
Alexey Filippenko
DEDmitriy Elesin
Dmitriy Elesin
Denis LosikDenis Losik
Denis Losik
AGAlexander Grishkov
Alexander Grishkov
VSVitaliy Shabanov
Vitaliy Shabanov

30 March 2023 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
Denis LosikDenis Losik
Denis Losik
VBV.V. Beloborodov
V.V. Beloborodov
EFE.V. Fisher
E.V. Fisher
VMV.I. Murtazin
V.I. Murtazin
AFA.G. Filippenko
A.G. Filippenko
ARAlexander Romanov
Alexander Romanov
Objective: To evaluate the model of atrial fibrillation (AF) in mini-pigs with endocardial approach implantation of CRT-P using bi-electrodes pacing through RV/LV connectors.Methods: All surgical interventions were minimally invasive and conducted under general anaesthesia. CRT-P was implanted endocardially, using X-ray. First electrode was fixed in the right atrial appendage. The second one — in the interatrial septum or the right atrial free wall. Both of them were connected with CRT-P through RV/LV. Bi-electrode atrial stimulation was realized during a week with a basic heart rate of 150 bpm and a delay between electrodes of 80 ms (mean 450 bpm), which corresponds to the heart rate (HR) of AF. Electrophysiological study was performed during the experiment to analyze the cardiac conduction system. AF inducibility was evaluated before and after stimulation.Results: A series of experiments demonstrated that there were no complications following the device and electrodes implantation. There was a non-sustained paroxysm of AF before permanent pacing in one of three pigs. After pacing we noted a tendency to increase the baseline HR (average frequency from 94 ± 4 to 98 ± 6 bpm). Non-sustained paroxysm of AF was induced in all cases. The sustained AF with 92 min burden was induced in one pig.Conclusion: Endocardial bi-electrode atrial pacing in mini-pigs has proven to be safe. This AF model improves AF inducibility and can be considered as an alternative to epicardial stimulation for experiments employing AF models. Received 4 December 2022. Revised 17 January 2023. Accepted 18 January 2023. Funding: The study was supported by Russian Science Foundation (project No. 22-25-00672). Conflict of interest: The authors declare no conflict of interest. Contribution of the authorsConception and study design: V.V. Beloborodov, D.V. Losik, E.V. FisherData collection and analysis: E.V. Fisher, V.V. Beloborodov, D.V. Losik, A.G. FilippenkoDrafting the article: D.V. Losik, E.V. Fisher, V.I. Murtazin, V.V. BeloborodovCritical revision of the article: A.B. Romanov, D.V. Losik, V.V. Shabanov, I.L. MikheenkoFinal approval of the version to be published: D.V. Losik, V.V. Beloborodov, E.V. Fisher, V.I. Murtazin, A.G. Filippenko, I.L. Mikheenko, V.V. Shabanov, A.B. Romanov